Covestor LTD Corcept Therapeutics Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Covestor LTD holds 343 shares of CORT stock, worth $22,953. This represents 0.01% of its overall portfolio holdings.

Number of Shares

343

Previous 326 5.21%

Holding current value

$22,953

Previous $10,000 60.0%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$29.51 - $46.26 $501 - $786	17 Added 5.21%	343 $16,000
Q2 2024 Aug 09, 2024	SELL	$22.21 - $34.48 $104,009 - $161,469	-4,683 Reduced 93.49%	326 $10,000
Q1 2024 May 10, 2024	BUY	$21.1 - $27.46 $25,678 - $33,418	1,217 Added 32.09%	5,009 $126,000
Q4 2023 Feb 09, 2024	SELL	$24.82 - $32.88 $26,706 - $35,378	-1,076 Reduced 22.1%	3,792 $123,000
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $1,120 - $1,723	-51 Reduced 1.04%	4,868 $133,000
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $63,891 - $74,947	2,980 Added 153.69%	4,919 $109,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $8,985 - $11,451	468 Added 31.82%	1,939 $42,000
Q4 2022 Feb 13, 2023	SELL	$19.95 - $29.96 $59 - $89	-3 Reduced 0.2%	1,471 $29,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $35,790 - $42,194	1,449 Added 5796.0%	1,474 $38,000
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $1,403 - $2,049	-81 Reduced 76.42%	25 $1,000
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $595 - $907	36 Added 51.43%	106 $2,000
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $1,197 - $1,633	70 New	70 $1,000

Others Institutions Holding CORT

# of Institutions

355

Shares Held

86.2M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account